Silicon Matrix Calcium Phosphate as a Bone Substitute: Early Clinical and Radiological Results in a Prospective Study With 12-Month Follow-up.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4365826)

Published in SAS J on June 01, 2008

Authors

Luiz Pimenta1, Carlos Fernando Arias Pesántez1, Leonardo Oliveira1

Author Affiliations

1: Santa Rita Hospital, Sao Paulo, Brazil.

Articles cited by this

The Oswestry Disability Index. Spine (Phila Pa 1976) (2000) 15.42

The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976) (2000) 2.87

Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech (2003) 1.69

Silicon: a possible factor in bone calcification. Science (1970) 1.68

Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res (1999) 1.37

A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics (2003) 1.12

Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach. Spine (Phila Pa 1976) (2002) 1.11

Bone formation induced by calcium phosphate ceramics in soft tissue of dogs: a comparative study between porous alpha-TCP and beta-TCP. J Mater Sci Mater Med (2001) 1.08

A synthetic porous ceramic as a bone graft substitute in the surgical management of scoliosis: a prospective, randomized study. Spine (Phila Pa 1976) (2000) 1.08

A prospective randomized comparison of coralline hydroxyapatite with autograft in cervical interbody fusion. Spine (Phila Pa 1976) (2003) 1.00

Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. Autograft versus coralline hydroxyapatite. Eur Spine J (2005) 0.98

Resorbable bioceramics based on stabilized calcium phosphates. Part II: evaluation of biological response. Biomaterials (2001) 0.94

In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials (2002) 0.94

Silicon: a requirement in bone formation independent of vitamin D1. Calcif Tissue Int (1981) 0.93

Osteopromotion by a beta-tricalcium phosphate/bone marrow hybrid implant for use in spine surgery. Spine (Phila Pa 1976) (2006) 0.93

Bone graft substitutes for spinal fusion. Spine J (2003) 0.92

Efficacy of silicated calcium phosphate graft in posterolateral lumbar fusion in sheep. Spine J (2006) 0.92

Posterior spinal fusion: allograft versus autograft bone. J Spinal Disord (1990) 0.86

Effect of bioactive ceramic dissolution on the mechanism of bone mineralization and guided tissue growth in vitro. J Biomed Mater Res A (2006) 0.83

Advanced bioceramic composite for bone tissue engineering: design principles and structure-bioactivity relationship. J Biomed Mater Res A (2004) 0.82